Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

BUY
$62.17 - $97.62 $435 - $683
7 Added 4.09%
178 $17,000
Q3 2022

Oct 31, 2022

SELL
$72.92 - $99.73 $1,677 - $2,293
-23 Reduced 11.86%
171 $13,000
Q2 2022

Jul 19, 2022

SELL
$84.23 - $147.57 $1,853 - $3,246
-22 Reduced 10.19%
194 $18,000
Q1 2022

May 03, 2022

SELL
$122.89 - $171.74 $4,792 - $6,697
-39 Reduced 15.29%
216 $30,000
Q4 2021

Feb 07, 2022

SELL
$156.0 - $265.78 $56,472 - $96,212
-362 Reduced 58.67%
255 $47,000
Q3 2021

Oct 25, 2021

SELL
$228.69 - $274.2 $67,006 - $80,340
-293 Reduced 32.2%
617 $160,000
Q2 2021

Jul 26, 2021

SELL
$169.89 - $231.37 $155,959 - $212,397
-918 Reduced 50.22%
910 $209,000
Q1 2021

Apr 27, 2021

BUY
$143.93 - $207.3 $263,104 - $378,944
1,828 New
1,828 $668,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.